Nonsteroidal Anti-inflammatory Drug class drugs

65 results

  • aspirin and extended-release dipyridamole

    (Aspirin and Extended-Release Dipyridamole)
    AvKARE
    Aspirin and extended-release dipyridamole capsules are indicated to reduce the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke caused by thrombosis.
    Medication Details
    Drug Interactions

  • asprin and extended-release dipyridamole

    (ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE)
    Glenmark Pharmaceuticals Inc., USA
    Aspirin and extended-release dipyridamole capsules are indicated for reducing the risk of stroke in patients with a history of transient ischemia of the brain or completed ischemic stroke due to thrombosis.
    Medication Details
    Drug Interactions

  • bromsite

    (bromfenac)
    Sun Pharmaceutical Industries, Inc.
    BromSite (bromfenac ophthalmic solution) 0.075% is indicated for treating postoperative inflammation and preventing ocular pain in patients who have undergone cataract surgery.
    Medication Details
    Drug Interactions

  • butalbital, aspirin, and caffeine

    (butalbital, aspirin, and caffeine)
    Chartwell RX, LLC
    Butalbital, aspirin, and caffeine capsules are indicated for relieving tension or muscle contraction headache symptoms. There is insufficient evidence for their efficacy in multiple recurrent headaches. Caution is advised due to the potential for habit formation and abuse associated with butalbital.
    Medication Details
    Drug Interactions

  • butalbital, aspirin, caffeine and codeine phosphate

    (BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATE)
    Amneal Pharmaceuticals of New York, LLC
    BUTALBITAL, ASPIRIN, CAFFEINE, and CODEINE PHOSPHATE are indicated for managing tension headaches when non-opioid analgesics are ineffective. Due to addiction risks, it is recommended for patients who cannot tolerate or do not achieve adequate relief from non-opioid treatments and should not be used long-term.
    Medication Details
    Drug Interactions

  • cambia

    (diclofenac potassium)
    Assertio Therapeutics, Inc.
    CAMBIA is indicated for the acute treatment of migraine attacks with or without aura in adults aged 18 and older. It is not intended for prophylactic therapy of migraine or for the treatment of cluster headache.
    Medication Details
    Drug Interactions

  • celebrex

    (Celecoxib)
    Viatris Specialty LLC
    CELEBREX is indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis in patients 2 years and older, ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.
    Medication Details
    Drug Interactions

  • celecoxib

    (CELECOXIB)
    NIVAGEN PHARMACEUTICALS, INC.
    Celecoxib capsules are indicated for managing signs and symptoms of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.
    Medication Details
    Drug Interactions

  • celecoxib

    (Celecoxib)
    Chartwell RX, LLC
    Celecoxib is indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (for patients aged 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.
    Medication Details
    Drug Interactions

  • celecoxib

    (Celecoxib)
    Qingdao BAHEAL Pharmaceutical Co., Ltd.
    Celecoxib capsules are indicated for the management of osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis (in patients 2 years and older), ankylosing spondylitis, acute pain in adults, and primary dysmenorrhea.
    Medication Details
    Drug Interactions